How technology is changing the detection of breast cancer

Dr. Rachel Brem, inspired by her mother’s battle with breast cancer, is dedicated to advancing breast cancer screening. As a diagnostic radiologist and director at George Washington University, she founded the Brem Foundation to combat breast cancer through early detection. Brem is optimistic about the role of artificial intelligence (AI) in revolutionizing breast cancer detection. Collaborating with ScreenPoint Medical, she helped develop Transpara, an AI software that enhances mammogram accuracy, potentially identifying cancer up to five years earlier and predicting future risks. Despite its promise, only 20% of practices nationwide use AI in mammograms, often due to additional costs. Brem emphasizes AI’s potential to address racial disparities in breast cancer outcomes, noting that Black women face a 40% higher mortality rate than White women. Her foundation focuses on equitable access to screenings and education. Brem is also involved in developing a breath test for breast cancer detection, highlighting her commitment to innovative solutions. QUESTION: How might the widespread adoption of AI in breast cancer screening change the future of healthcare and patient outcomes?